These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 12757979)

  • 1. Telomerase inhibition as cancer therapy.
    Saretzki G
    Cancer Lett; 2003 May; 194(2):209-19. PubMed ID: 12757979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase as a promising target for human cancer gene therapy.
    Saretzki G; von Zglinicki T
    Drugs Today (Barc); 2003 Apr; 39(4):265-76. PubMed ID: 12743642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomerase regulation: a key to inhibition? (Review).
    Gómez DL; Farina HG; Gómez DE
    Int J Oncol; 2013 Nov; 43(5):1351-6. PubMed ID: 24042470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer therapy targeting telomeres and telomerase : current status.
    Parkinson EK; Minty F
    BioDrugs; 2007; 21(6):375-85. PubMed ID: 18020621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase inhibitors as anticancer therapy.
    Akiyama M; Hideshima T; Munshi NC; Anderson KC
    Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):567-75. PubMed ID: 12678724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting human telomerase in cancer therapy.
    Huard S; Autexier C
    Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):577-87. PubMed ID: 12678725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase: a potential therapeutic target for cancer.
    Fletcher TM
    Expert Opin Ther Targets; 2005 Jun; 9(3):457-69. PubMed ID: 15948667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stilbene Compounds Inhibit Tumor Growth by the Induction of Cellular Senescence and the Inhibition of Telomerase Activity.
    Lee YH; Chen YY; Yeh YL; Wang YJ; Chen RJ
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31159515
    [No Abstract]   [Full Text] [Related]  

  • 9. How to inhibit telomerase activity for cancer therapy.
    Kyo S; Inoue M
    Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):613-26. PubMed ID: 12678728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing Direction: From Therapeutic Telomerase Inhibition to Activation?
    Bär C; Thum T
    Circ Res; 2017 Apr; 120(9):1393-1395. PubMed ID: 28450362
    [No Abstract]   [Full Text] [Related]  

  • 11. Targeting telomeres and telomerase.
    De Cian A; Lacroix L; Douarre C; Temime-Smaali N; Trentesaux C; Riou JF; Mergny JL
    Biochimie; 2008 Jan; 90(1):131-55. PubMed ID: 17822826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase as a target for cancer therapy.
    Parkinson KE
    Curr Opin Investig Drugs; 2005 Jun; 6(6):605-10. PubMed ID: 15988912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase as a Cancer Target. Development of New Molecules.
    Gomez DL; Armando RG; Cerrudo CS; Ghiringhelli PD; Gomez DE
    Curr Top Med Chem; 2016; 16(22):2432-40. PubMed ID: 26873194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
    Tárkányi I; Aradi J
    Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase as an emerging target to fight cancer--opportunities and challenges for nanomedicine.
    Philippi C; Loretz B; Schaefer UF; Lehr CM
    J Control Release; 2010 Sep; 146(2):228-40. PubMed ID: 20381558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase inhibition and cancer: might platinum based drugs have a future as anti-telomerase pharmacological approach?
    Colangelo D; Osella D
    Curr Med Chem; 2005; 12(26):3091-102. PubMed ID: 16375703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bortezomib-mediated down-regulation of telomerase and disruption of telomere homeostasis contributes to apoptosis of malignant cells.
    Ci X; Li B; Ma X; Kong F; Zheng C; Björkholm M; Jia J; Xu D
    Oncotarget; 2015 Nov; 6(35):38079-92. PubMed ID: 26472030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomerase, cell immortality, and cancer.
    Harley CB; Kim NW; Prowse KR; Weinrich SL; Hirsch KS; West MD; Bacchetti S; Hirte HW; Counter CM; Greider CW
    Cold Spring Harb Symp Quant Biol; 1994; 59():307-15. PubMed ID: 7587082
    [No Abstract]   [Full Text] [Related]  

  • 19. Telomerase inhibition is a specific early event in salvicine-treated human lung adenocarcinoma A549 cells.
    Liu WJ; Zhang YW; Shen Y; Jiang JF; Miao ZH; Ding J
    Biochem Biophys Res Commun; 2004 Oct; 323(2):660-7. PubMed ID: 15369801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomere biology of pediatric cancer.
    Tabori U; Dome JS
    Cancer Invest; 2007; 25(3):197-208. PubMed ID: 17530490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.